Encompass Health EBITDA 2010-2024 | EHC

Encompass Health annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Encompass Health EBITDA for the quarter ending September 30, 2024 was $0.289B, a 12.48% increase year-over-year.
  • Encompass Health EBITDA for the twelve months ending September 30, 2024 was $1.083B, a 12.63% increase year-over-year.
  • Encompass Health 2023 annual EBITDA was $1.015B, a 15.09% increase from 2022.
  • Encompass Health 2022 annual EBITDA was $0.882B, a 0.42% decline from 2021.
  • Encompass Health 2021 annual EBITDA was $0.886B, a 20.44% increase from 2020.
Encompass Health Annual EBITDA
(Millions of US $)
2023 $1,015
2022 $882
2021 $886
2020 $736
2019 $908
2018 $833
2017 $831
2016 $835
2015 $678
2014 $575
2013 $582
2012 $503
2011 $465
2010 $400
2009 $335
Encompass Health Quarterly EBITDA
(Millions of US $)
2024-06-30 $289
2024-03-31 $278
2023-12-31 $270
2023-09-30 $247
2023-06-30 $257
2023-03-31 $243
2022-12-31 $252
2022-09-30 $211
2022-06-30 $210
2022-03-31 $210
2021-12-31 $130
2021-09-30 $204
2021-06-30 $281
2021-03-31 $270
2020-12-31 $103
2020-09-30 $234
2020-06-30 $160
2020-03-31 $239
2019-12-31 $218
2019-09-30 $227
2019-06-30 $223
2019-03-31 $240
2018-12-31 $168
2018-09-30 $224
2018-06-30 $226
2018-03-31 $215
2017-12-31 $214
2017-09-30 $208
2017-06-30 $202
2017-03-31 $208
2016-12-31 $220
2016-09-30 $206
2016-06-30 $207
2016-03-31 $203
2015-12-31 $185
2015-09-30 $170
2015-06-30 $171
2015-03-31 $152
2014-12-31 $137
2014-09-30 $141
2014-06-30 $154
2014-03-31 $143
2013-12-31 $149
2013-09-30 $155
2013-06-30 $135
2013-03-31 $143
2012-12-31 $130
2012-09-30 $125
2012-06-30 $123
2012-03-31 $125
2011-12-31 $114
2011-09-30 $113
2011-06-30 $120
2011-03-31 $118
2010-12-31 $99
2010-09-30 $99
2010-06-30 $96
2010-03-31 $106
2009-12-31 $78
2009-09-30 $89
2009-06-30 $56
2009-03-31 $111
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.267B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00